Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2739 (LINC02739) is a non-protein coding RNA belonging to the long intergenic noncoding RNA class, which are typically defined as transcripts over 200 nucleotides in length that arise independently from protein-coding genes and do not overlap known coding regions[1][5]. The gene is annotated in multiple databases (NCBI Gene: 105369317; Ensembl: ENSG00000255008), and is affiliated with the lncRNA molecular class. LINC02739 may be predicted to have RNA-based biological roles such as involvement in translation, RNA binding, or regulation of gene expression, which are characteristic of lincRNAs. However, there are currently no validated specific biological functions, disease roles, drug interactions, or biomarker indications for LINC02739, and it is not recognized as a therapeutic target or receptor[5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2739 (LINC02739).